Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Oct - Please find attached herewith Newspaper Publication.
Source: Bse
FMCG stocks · Mid cap · NSE
Colgate-Palmolive (India) Limited is a leading consumer goods company focused on oral care, including toothpaste and toothbrushes, and personal care products like hand and body wash. It emphasizes driving category consumption, premiumization, and strong brand health through extensive distribution and R&D.
full bear SMA stack · SMA20 -2.4% / mo · MACD + · near 52W low · sector -4.5pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +11.8% · PAT +6.8% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
margin compression · Rev +12% YoY · PAT +7% YoY
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,603 Cr | +11.8% | +0.5% |
| EBITDA | ₹483 Cr | +6.6% | -5.3% |
| Operating margin | 30.0% | -200 bps | -200 bps |
| PAT | ₹343 Cr | +6.8% | -2.8% |
| PAT margin | 21.4% | -98 bps | -73 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term trend down. RSI 41.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 50 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 FY26 domestic net sales grew 9.2% YoY, showing significant acceleration after a flat full year. Gross margins remained strong at 69.6%, with EBITDA at 32.2%, despite increased brand investments and commodity/currency headwinds.
COLPAL's Q4 performance indicates a positive shift, driven by premiumization and increased brand investments. While full-year growth was muted, the sequential improvement and resilient margins are encouraging. The focus on driving consumption and expanding distribution, coupled with AI adoption, positions the company for potential long-term growth, though rural demand trends need monitoring.
Accelerated investments behind Premium portfolio (Colgate Total, Visible White, PerioGard) showing significant elasticity on advertising.
Significant growth opportunity in India, playing across value, mid-tier, premium, and kids segments, with new brushes launched.
Relaunched Colgate Strong Teeth with superior formulation (arginine plus calcium boost), Max Fresh continues to be the fastest growing franchise.
Palmolive Hand Wash and Body Wash growing strongly, Moments Range innovation, and a new digital-first approach for Body Wash.
Urban markets are now beginning to pick up in terms of growth, off a relatively soft base.
E-commerce as a channel is growth-accretive, margin-accretive, share-accretive, and premiumization-accretive for the company.
Seeing significant elasticity behind increased brand investments, particularly on the Premium portfolio.
The GST IDS impact will be an ongoing thing and will come through every quarter, affecting operating profit.
Despite these headwinds, the company continues to deliver very good margins.
There is a slight slowdown in rural growth, though it is still expected to grow faster than urban.
Value growth pickup in Nielsen will be quite distorted given that MRP pricing has actually gone down due to GST.
While claimed results for brushing habits are positive, only some of it will translate into actual behavior.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
Q4 YoY growth shows recent acceleration, while full-year performance was flat due to earlier tough quarters. Sequential improvement in H2 over H1 indicates momentum, making both comparisons relevant to assess current trajectory and underlying business health.
Domestic growth now at 9.2% YoY for Q4 FY26.
Gross margins continue to be strong at 69.6% for Q4 FY26 and 69.3% for the full year.
EBITDA margins at 32.2% for Q4 FY26 (includes 160 bps GST IDS impact) and 31.2% for full year FY26 (includes 80 bps GST IDS impact).
Brand investments just under Rs. 200 crores in Q4 FY26, representing a 10% increase from the same quarter previous year.
Entering Calendar Year 2026 with a renewed sense of optimism and confidence in terms of what this business can deliver.
Focus continues to be to build category consumption and therefore drive volume.
Transformatively accelerate Oral Care Premiumization, which has seen a step change.
Using Google AI technology to drive effectiveness, efficiency, and capability across the organization, with near universal adoption.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Domestic Volume Growth | Overall market is flat-to-increasing. | Need to continuously look at volume growth because value growth pickup in Nielsen will be distorted by GST impact on pricing. |
| Premiumization Contribution | Premiumization mix is up 35% over two years. | Monitor continued growth and margin accretion from the premium segment, especially with accelerated investments. |
| Rural Demand Trends | Rural markets seeing a slight slowdown. | Observe if rural growth picks up and converges with urban trends, and the effectiveness of rural consumption initiatives. |
| EBITDA Margin Calibration | EBITDA margin for Q4 FY26 is 32.2% (including 160 bps GST IDS impact). | EBITDA will be calibrated depending on advertising support and response; watch for sustained industry-leading margins. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 98th percentile of the scored universe and 91st percentile within FMCG. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · FMCG: 91st pctile, median 79 · Mid: 93rd pctile, median 76
70 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse